Get the Stockscreener App
92.90
0.05%
0.05
After Hours:
92.85
-0.05
-0.05%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Medtronic Plc stock is traded at $92.90, with a volume of 4.86M.
It is up +0.05% in the last 24 hours and up +3.60% over the past month.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
See More
Previous Close:
$92.85
Open:
$93.14
24h Volume:
4.86M
Relative Volume:
0.67
Market Cap:
$119.16B
Revenue:
$34.20B
Net Income/Loss:
$4.69B
P/E Ratio:
25.59
EPS:
3.63
Net Cash Flow:
$5.30B
1W Performance:
+0.10%
1M Performance:
+3.60%
6M Performance:
-1.23%
1Y Performance:
+3.93%
1-Day Range:
$92.52
$93.94
1-Week Range:
$91.42
$94.35
52-Week Range:
$79.29
$96.25
Medtronic Plc Stock (MDT) Company Profile
Name
Medtronic Plc
Sector
Industry
Phone
01135314381700
Address
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
92.90 | 119.10B | 34.20B | 4.69B | 5.30B | 3.63 |
|
ABT
Abbott Laboratories
|
132.94 | 231.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.22 | 158.98B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
392.31 | 150.76B | 23.82B | 2.92B | 4.02B | 7.55 |
|
EW
Edwards Lifesciences Corp
|
80.94 | 47.53B | 5.69B | 1.41B | 577.90M | 6.95 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-30-25 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Oct-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-21-24 | Reiterated | Oppenheimer | Perform |
| Aug-15-24 | Upgrade | UBS | Sell → Neutral |
| Aug-14-24 | Downgrade | Stifel | Buy → Hold |
| May-30-24 | Initiated | Goldman | Sell |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-24-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-29-23 | Downgrade | UBS | Buy → Sell |
| Jan-09-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-23-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-23-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-16-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Aug-24-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Jun-01-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-17-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Jun-10-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Dec-15-20 | Upgrade | Goldman | Sell → Neutral |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-08-20 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-08-20 | Upgrade | Stifel | Hold → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| May-14-20 | Downgrade | DZ Bank | Buy → Hold |
| Mar-30-20 | Downgrade | Needham | Strong Buy → Buy |
| Mar-25-20 | Upgrade | DZ Bank | Hold → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Sell |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-02-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jun-05-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Feb-04-19 | Reiterated | Needham | Strong Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-27-18 | Reiterated | Argus | Buy |
View All
Medtronic Plc Stock (MDT) Latest News
What is Medtronic plc’s TAM (Total Addressable Market)Weekly Trade Recap & Technical Pattern Based Signals - خودرو بانک
Medtronic heads into Q1 with softer profit sentiment - MSN
Will Medtronic plc benefit from AI trendsQuarterly Performance Summary & Technical Confirmation Alerts - خودرو بانک
How hedge fund analytics apply to Medtronic plc stockOil Prices & Accurate Technical Buy Alerts - Newser
How to escape a deep drawdown in Medtronic plcQuarterly Profit Review & Daily Price Action Insights - Newser
Medtronic trial of Hugo robot in hernia repair hits primary endpoints - MedTech Dive
Medtronic's Hugo Robotic System Achieves 100% Success Rate In Hernia Repair TrialMedtronic (NYSE:MDT) - Benzinga
AI firm Ketryx raises $39M, adds former Medtronic CEO as investor - MedTech Dive
MDT Stock May Benefit From New Regulatory Wins for Its MiniMed 780G - TradingView
Study of Medtronic Hugo™ robotic-assisted surgery system in hernia repair meets safety and effectiveness endpoints - biospace.com
Trend Recap: What drives Medtronic plc’s stock priceNew Guidance & Daily Oversold Stock Bounce Ideas - خودرو بانک
Sentiment analysis tools applied to Medtronic plc2025 Price Targets & Safe Entry Trade Signal Reports - Newser
How Medtronic Plc. (MDT) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Medtronic Hits Milestone with Hugo Surgical Robot - Medical Device and Diagnostic industry
Medtronic (MDT) Collaborates with Orchestra BioMed on Promising AVIM Therapy - GuruFocus
Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout - GlobeNewswire Inc.
Medtronic Hugo surgical robot meets endpoints in hernia repair study - MassDevice
Medtronic (MDT) Shares Rise with Hugo Surgical System Success - GuruFocus
Medtronic succeeds in Hugo robotic-assisted surgery system study - MSN
Medtronic's Surgery System for Hernia Repair Meets Safety, Effectiveness Endpoints - MarketScreener
Medtronic Says Study of Robotic-Assisted Hernia Repair System Met Primary Endpoint - MarketScreener
Medtronic’s Hugo robotic system meets endpoints in hernia repair study - Investing.com
Medtronic plc Announces Results from the Enable Hernia Repair Clinical Study Evaluating the Performance of the Hugo Robotic-Assisted Surgery System in Inuinal and Ventral Hernia Repair Procedures - MarketScreener
Saudi Arabia Smart Hospital Market Forecast and Company Analysis Report 2025-2033 Featuring Koninklijke Philips, Medtronic, SAP, Cerner, and Schneider Electric Healthcare - Yahoo Finance
Transcript : Medtronic plc Presents at Wells Fargo 20th Annual Healthcare Conference 2025, Sep-04-2025 08 - MarketScreener
Can Medtronic plc sustain earnings growthWeekly Investment Report & Expert Verified Movement Alerts - خودرو بانک
Insights Into the $50+ Billion Urology Care Devices & Platforms Market 2025-2030 Featuring Boston Scientific, Olympus, Medtronic, Coloplast, and BD Among Other Industry Giants - uk.finance.yahoo.com
Does Medtronic plc offer margin of safetyWeekly Stock Report & Reliable Price Action Trade Plans - khodrobank.com
Medtronic Symplicity Spyral renal denervation tech wins regulatory nod in Japan - MassDevice
Edwards, Medtronic and Abbott stand to benefit from new TAVR guidelines in Europe - MedTech Dive
Medtronic's (NYSE:MDT) Solid Earnings Are Supported By Other Strong Factors - simplywall.st
Reversal indicators forming on Medtronic plc stockEarnings Risk Report & Community Driven Trade Alerts - Newser
Medtronic Stock: Is MDT Outperforming the Healthcare Sector? - Yahoo Finance
Cryotherapy Device Market Insights Report 2025-2030 with Exclusive Data on 25 Vendors Including Boston Scientific, Cryo Innovations, MECOTEC, Medtronic, Metrum Cryoflex, and Zimmer MedizinSysteme - Yahoo Finance
Identifying reversal signals in Medtronic plcJuly 2025 Final Week & Risk Managed Investment Signals - Newser
Medtronic Stock: Is MDT Outperforming The Healthcare Sector? - Barchart.com
Analyzing recovery setups for Medtronic plc investors2025 Dividend Review & Technical Confirmation Trade Alerts - Newser
Building trade automation scripts for Medtronic plc2025 Trade Ideas & Weekly Top Performers Watchlists - Newser
Precision Trading with Medtronic Plc. (MDT) Risk Zones - news.stocktradersdaily.com
Medtronic Receives FDA Clearance for MiniMed-Abbott Sensor Integration and Approval for Type 2 Diabetes Use - Medical Device and Diagnostic industry
Medtronic advances Abbott partnership with FDA nod - MedTech Dive
FDA Approves Medtronic's (MDT) MiniMed 780G Pump for Broader Use - GuruFocus
Medtronic wins FDA nod to integrate Abbott’s Instinct sensor with MiniMed 780G - Seeking Alpha
Medtronic data highlights safety, performance of OmniaSecure defibrillation lead - MassDevice
Medtronic gets FDA OK to integrate Minimed with Abbott’s Instinct - BioWorld MedTech
What candlestick patterns are forming on Medtronic plc2025 Market Sentiment & Daily Stock Trend Reports - Newser
TD Cowen Affirms Buy Rating on Medtronic, Inc. (MDT) on RDN Therapy Prospects - Yahoo Finance
Medtronic gets FDA nods for MiniMed 780G with Abbott Instinct sensor, expansion to type 2 - MassDevice
Medtronic Says FDA Clears Diabetes Treatment System for Integration With Abbott's Instinct Sensor - MarketScreener
Medtronic : Compelling data at ESC Congress 2025 reinforce safety and performance of the Medtronic OmniaSecure™ defibrillation lead, including in the left bundle branch area - MarketScreener
FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes - Medtronic
Medtronic Plc Stock (MDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.51%
2.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):